Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Acq. announced Quarterly results Consulting agrmnt CC transcript
|
LABORATORY CORP OF AMERICA HOLDINGS (LH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/12/2023 |
8-K
| Quarterly results |
09/29/2023 |
8-K
| Quarterly results |
08/10/2023 |
4
| ANDERSON KERRII B (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Sold 5,000 shares
@ $211.5665, valued at
$1.1M
|
|
08/09/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/03/2023 |
4
| Wilkinson Peter J (SVP, Chief Accounting Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Paid exercise price by delivering 17 shares
@ $213.61, valued at
$3.6k
Exercised 56 restricted stock units
@ $0 |
|
07/31/2023 |
8-K
| Quarterly results |
07/27/2023 |
8-K
| Quarterly results |
07/24/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/13/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
07/07/2023 |
8-K/A
| Financial Statements and Exhibits Interactive Data |
07/05/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 6,207 restricted stock units
@ $0 |
|
07/05/2023 |
4
| Wilkinson Peter J (SVP, Chief Accounting Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 3,104 restricted stock units
@ $0 |
|
07/05/2023 |
4
| Summy Amy B. (EVP, Chief Marketing Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 5,824 restricted stock units
@ $0 |
|
07/05/2023 |
4
| Schroeder Mark S (EVP, Pres Diagnostics & COO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 11,648 restricted stock units
@ $0 |
|
07/05/2023 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 73,013 restricted stock units
@ $0 |
|
07/05/2023 |
4
| EISENBERG GLENN A (CFO, EVP) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 20,193 restricted stock units
@ $0 |
|
07/05/2023 |
4
| DiVincenzo Jonathan P. (EVP, Pres, Central Labs & Intl) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 3,036 restricted stock units
@ $0 |
|
07/05/2023 |
4
| Caveney Brian J (EVP, Pres of ED, CMO & CSO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 11,648 restricted stock units
@ $0 |
|
07/05/2023 |
4
| BERBERIAN LANCE (EVP, CIO & CTO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 7,758 restricted stock units
@ $0 |
|
07/03/2023 |
4
| van der Vaart Sandra D (EVP, Chief Legal Officer) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Sold 212 shares
@ $240, valued at
$50.9k
|
|
07/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial State... |
06/29/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
06/12/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
06/09/2023 |
3
| LABORATORY CORP OF AMERICA HOLDINGS (10% Owner) has filed a Form 3 on Fortrea Holdings Inc. |
06/09/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
06/08/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
06/08/2023 |
4
| Rothman Paul (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Granted 642 restricted stock units
@ $0 |
|
06/07/2023 |
3
| Rothman Paul (Director) has filed a Form 3 on LABORATORY CORP OF AMERICA HOLDINGS |
06/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/31/2023 |
SD
| Form SD - Specialized disclosure report: |
05/23/2023 |
4
| Kirchgraber Paul R (CEO, Covance Drug Development) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS
Txns:
| Sold 4,300 shares
@ $216.9086, valued at
$932.7k
Exercised 4,300 options to buy
@ $182.51, valued at
$784.8k
|
|
05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
|
|
|